Jonna Levola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jonna Levola has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Solja Niemelä
Addiction Psychiatry Unit, Department of Psychiatry, Turku University Hospital, The wellbeing services county of Southwest Finland, Turku, Finland
5 shared publications- Tuuli Pitkänen
Finnish Youth Research Society, Helsinki, Finland
5 shared publications Annika Thomson
Helsingin ja Uudenmaan sairaanhoitopiiri
4 shared publications- Antti Mustonen
Tampere University
4 shared publications Eila Sailas
Helsingin ja Uudenmaan sairaanhoitopiiri
4 shared publicationsJouko Miettunen
Research Unit of Population Health, University of Oulu, Oulu, Finland
4 shared publications
Latest Publications
- 15 October 2026
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 40 (4)
Worries concerning a scientific review article on the cognitive effects of cannabis in psychotic patients
- 15 October 2026
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 40 (4)
Worries concerning a scientific review article on the cognitive effects of cannabis in psychotic patients
- Open Access
- 10 June 2026
- Published by Elsevier in SSRN Electronic Journal
Predictive Validity of the AUDIT-C Test for Various Somatic Conditions and Injuries Across Age Groups: A Finnish Registry-Based Study
Background: The Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) is a widely used screening instrument to identify hazardous alcohol consumption. We examined the capability of AUDIT-C to predict future risk for 23 outcomes including 21 somatic conditions, accidents, and mortality in the whole population and by age group and sex. Methods: We used data from a series of cross-sectional nationwide general population health surveys conducted in 2011-2017 and followed up using registers. The number of participants aged ≥20 years totaled 103,397 and the maximum register-based follow-up period was 12·4 years. Hazardous alcohol consumption was defined by AUDIT-C using sex-specific cut-offs (≥6 for men and ≥5 for women). Information on mortality, incident somatic morbidity, and accidents were obtained from national registers. Adjusted Cox proportional hazards models, stratified by sex and age group (< 40, 40–64, ≥65 years) were used to estimate predictive associations between AUDIT-C and 23 outcomes. Findings: Participants exceeding the AUDIT-C cut-off comprised 20.0% of respondents (N=20,629). After adjustments, exceeding the AUDIT-C cut-off was associated with elevated incident risk of various adverse outcomes, including mortality, accidents, alcohol-related conditions, liver diseases, gout, hypertensive diseases, atrial fibrillation, and breast, colon and oral cancer. Elevation in risk across the 23 endpoints was most clearly observed in individuals aged 40–64 years with statistically significant associations observed in 12 endpoints among men and in 11 among women. Interpretations: Our findings support the utility of AUDIT-C as a predictor for incident somatic morbidity and mortality risk. A simple and rapid AUDIT-C test may yield significantly more insight into individuals´ future health outcomes than previously assumed.
- 10 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPredictive Validity of the AUDIT-C Test for Various Somatic Conditions and Injuries Across Age Groups: A Finnish Registry-Based Study
Background: The Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) is a widely used screening instrument to identify hazardous alcohol consumption. We examined the capability of AUDIT-C to predict future risk for 23 outcomes including 21 somatic conditions, accidents, and mortality in the whole population and by age group and sex. Methods: We used data from a series of cross-sectional nationwide general population health surveys conducted in 2011-2017 and followed up using registers. The number of participants aged ≥20 years totaled 103,397 and the maximum register-based follow-up period was 12·4 years. Hazardous alcohol consumption was defined by AUDIT-C using sex-specific cut-offs (≥6 for men and ≥5 for women). Information on mortality, incident somatic morbidity, and accidents were obtained from national registers. Adjusted Cox proportional hazards models, stratified by sex and age group (< 40, 40–64, ≥65 years) were used to estimate predictive associations between AUDIT-C and 23 outcomes. Findings: Participants exceeding the AUDIT-C cut-off comprised 20.0% of respondents (N=20,629). After adjustments, exceeding the AUDIT-C cut-off was associated with elevated incident risk of various adverse outcomes, including mortality, accidents, alcohol-related conditions, liver diseases, gout, hypertensive diseases, atrial fibrillation, and breast, colon and oral cancer. Elevation in risk across the 23 endpoints was most clearly observed in individuals aged 40–64 years with statistically significant associations observed in 12 endpoints among men and in 11 among women. Interpretations: Our findings support the utility of AUDIT-C as a predictor for incident somatic morbidity and mortality risk. A simple and rapid AUDIT-C test may yield significantly more insight into individuals´ future health outcomes than previously assumed.
- Open Access
Predictive validity of Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) for register‐based alcohol‐attributable events among general‐population men and women of different ages
Background and aims: Originally developed for clinical screening for hazardous alcohol use, the Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) is also widely used in epidemiological research and monitoring. However, its cutoff values may not suit all purposes, and evidence on its predictive validity is limited. We examined how AUDIT‐C scores relate to subsequent register‐based alcohol‐attributable events across age and sex and identified optimal thresholds for predicting these outcomes. Design: Five general population surveys conducted in 2011–2017, linked to nationwide registers with follow‐up until the end of 2023 (total follow‐up 879 964 person‐years). Setting: Nationwide, Finland. Participants: Adults aged ≥20 years ( n = 103 567). Measurements: AUDIT‐C to assess exposure. Outcome: incident alcohol‐attributable events in any of the registers capturing care, deaths and prescription medicines ( n = 1444). Findings: The hazard of register‐based alcohol‐attributable events increased approximately exponentially with increasing AUDIT‐C score. It rose more strongly among women than men [hazard ratio (HR) = 1.61, 95% confidence interval (CI) = 1.55–1.67 for women; HR = 1.45, 95% CI = 1.40–1.49 for men; P < 0.001 for the sex × AUDIT‐C interaction]. The risk of alcohol‐attributable events was statistically significantly raised at 2 points among women and 3 points among men with 1 point as a reference level. The suggested optimal cutoff values were 2 points for women aged ≥80, 3 points for women aged 65–79 and men aged ≥80, 5 points for women aged 20–64 and men aged 65–79 and 6 points for men aged 20–64. Conclusions: Using Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) scores, optimal cutoff values for predicting alcohol‐attributable harm may differ by age and sex, with lower cutoffs for older individuals and women. The ≥65 age group appears to be heterogeneous with regard to vulnerability to alcohol‐attributable harm, which should be considered when establishing cutoffs or guidelines for alcohol use.
Open AccessPredictive validity of Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) for register‐based alcohol‐attributable events among general‐population men and women of different ages
Background and aims: Originally developed for clinical screening for hazardous alcohol use, the Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) is also widely used in epidemiological research and monitoring. However, its cutoff values may not suit all purposes, and evidence on its predictive validity is limited. We examined how AUDIT‐C scores relate to subsequent register‐based alcohol‐attributable events across age and sex and identified optimal thresholds for predicting these outcomes. Design: Five general population surveys conducted in 2011–2017, linked to nationwide registers with follow‐up until the end of 2023 (total follow‐up 879 964 person‐years). Setting: Nationwide, Finland. Participants: Adults aged ≥20 years ( n = 103 567). Measurements: AUDIT‐C to assess exposure. Outcome: incident alcohol‐attributable events in any of the registers capturing care, deaths and prescription medicines ( n = 1444). Findings: The hazard of register‐based alcohol‐attributable events increased approximately exponentially with increasing AUDIT‐C score. It rose more strongly among women than men [hazard ratio (HR) = 1.61, 95% confidence interval (CI) = 1.55–1.67 for women; HR = 1.45, 95% CI = 1.40–1.49 for men; P < 0.001 for the sex × AUDIT‐C interaction]. The risk of alcohol‐attributable events was statistically significantly raised at 2 points among women and 3 points among men with 1 point as a reference level. The suggested optimal cutoff values were 2 points for women aged ≥80, 3 points for women aged 65–79 and men aged ≥80, 5 points for women aged 20–64 and men aged 65–79 and 6 points for men aged 20–64. Conclusions: Using Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) scores, optimal cutoff values for predicting alcohol‐attributable harm may differ by age and sex, with lower cutoffs for older individuals and women. The ≥65 age group appears to be heterogeneous with regard to vulnerability to alcohol‐attributable harm, which should be considered when establishing cutoffs or guidelines for alcohol use.
- Open Access
- 21 January 2026
- Published by SAGE Publications in Journal of Telemedicine and Telecare
- Vol. 32 (7) , 601-611
Global perspectives on telemedicine-enabled medications for opioid use disorder: Practices, priorities, and barriers
Introduction: Telemedicine (TM) has potential to address the global opioid use disorder treatment gap, yet its uptake, priorities, and barriers have not been mapped internationally. Methods: We conducted a cross-sectional, web-based survey (July to November 2024) of clinicians and clinical leaders via the International Society of Addiction Medicine, World Psychiatric Association, and allied contacts. The questionnaire captured telemedicine facilitated medication for opioid use disorder (TMOUD) practices, priorities, and barriers. Responses were summarised overall and stratified by World Bank country-income group and by current TMOUD availability. Results: Sixty-eight experts from 37 countries, 32% from low/middle-income countries (LMICs), participated. General TM use rose from 57% before COVID-19 to 94% in 2024. TMOUD was available in 26 jurisdictions (38%), more often in high-income than LMIC settings (58% vs 11%). Barriers to prescribing were identified, and few settings reimbursed video and telephone consultations equally. Improving treatment retention (69%), reducing missed appointments (62%), and expanding medications to underserved (60%) or remote (57%) populations as top priorities, yet fewer than 40% reported that TMOUD was currently used to meet those goals. Key barriers were inadequate policy support (60%), lack of professional guidance (63%), restrictive regulation (48%), poor digital infrastructure (broadband 29%; e-prescribing 56%), and limited clinician training (54%); almost every barrier was more common in LMICs. Discussion: TMOUD remains uneven and concentrated in high-income countries. Updated clinical guidance, digital connectivity investment and interoperable e-health systems, and targeted workforce development, particularly in LMICs, are needed to realise TM's potential for equitable and effective treatment of opioid use disorder. This global survey fills a critical knowledge gap by documenting expert perspectives across income settings, offering cross-national evidence to inform equitable expansion of TMOUD worldwide.
- 21 January 2026
- Published by SAGE Publications in Journal of Telemedicine and Telecare
- Vol. 32 (7) , 601-611
Open AccessGlobal perspectives on telemedicine-enabled medications for opioid use disorder: Practices, priorities, and barriers
Introduction: Telemedicine (TM) has potential to address the global opioid use disorder treatment gap, yet its uptake, priorities, and barriers have not been mapped internationally. Methods: We conducted a cross-sectional, web-based survey (July to November 2024) of clinicians and clinical leaders via the International Society of Addiction Medicine, World Psychiatric Association, and allied contacts. The questionnaire captured telemedicine facilitated medication for opioid use disorder (TMOUD) practices, priorities, and barriers. Responses were summarised overall and stratified by World Bank country-income group and by current TMOUD availability. Results: Sixty-eight experts from 37 countries, 32% from low/middle-income countries (LMICs), participated. General TM use rose from 57% before COVID-19 to 94% in 2024. TMOUD was available in 26 jurisdictions (38%), more often in high-income than LMIC settings (58% vs 11%). Barriers to prescribing were identified, and few settings reimbursed video and telephone consultations equally. Improving treatment retention (69%), reducing missed appointments (62%), and expanding medications to underserved (60%) or remote (57%) populations as top priorities, yet fewer than 40% reported that TMOUD was currently used to meet those goals. Key barriers were inadequate policy support (60%), lack of professional guidance (63%), restrictive regulation (48%), poor digital infrastructure (broadband 29%; e-prescribing 56%), and limited clinician training (54%); almost every barrier was more common in LMICs. Discussion: TMOUD remains uneven and concentrated in high-income countries. Updated clinical guidance, digital connectivity investment and interoperable e-health systems, and targeted workforce development, particularly in LMICs, are needed to realise TM's potential for equitable and effective treatment of opioid use disorder. This global survey fills a critical knowledge gap by documenting expert perspectives across income settings, offering cross-national evidence to inform equitable expansion of TMOUD worldwide.
- 30 November 2025
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 80 (1) , 66-73
Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder
Alcohol use and daily smoking are common among individuals with schizophrenia spectrum disorder but less is known about their relationship to psychotic symptom profile and severity, and how clozapine use may affect this relationship. Among a clinical sample of 276 Finnish outpatients with schizophrenia spectrum disorder (68.8% schizophrenia), the Brief Psychiatric Rating Scale (BPRS) and the Scale for the Assessment of Negative Symptoms (SANS) were used to determine severity of psychotic symptoms. Information regarding alcohol use was collected with questionnaires including the Alcohol Use Disorders Identification Test-Concise (AUDIT-C) and information of smoking. Associations between psychiatric symptoms and substance use were studied using linear regression separately for those with or without clozapine use. Age, gender, marital status, living situation and education were adjusted for in the final analyses. In the multivariable models, heavy alcohol use and binge drinking were less frequent among participants with clozapine use (n = 115) compared to those without (n = 161). Differences in some symptoms were observed in bivariate analyses when comparing the participants with and without heavy or binge drinking, or daily smoking. Heavy and binge drinking were associated with more severe grandiosity symptoms even after controlling for potential confounders. Daily smoking was associated with more severe hostility, elated mood, unusual thought content and uncooperativeness, but less severe emotional withdrawal. Symptom profiles and severity differed according to alcohol use or smoking. The possible explanations for the role of clozapine are discussed.
- 30 November 2025
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 80 (1) , 66-73
Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder
Alcohol use and daily smoking are common among individuals with schizophrenia spectrum disorder but less is known about their relationship to psychotic symptom profile and severity, and how clozapine use may affect this relationship. Among a clinical sample of 276 Finnish outpatients with schizophrenia spectrum disorder (68.8% schizophrenia), the Brief Psychiatric Rating Scale (BPRS) and the Scale for the Assessment of Negative Symptoms (SANS) were used to determine severity of psychotic symptoms. Information regarding alcohol use was collected with questionnaires including the Alcohol Use Disorders Identification Test-Concise (AUDIT-C) and information of smoking. Associations between psychiatric symptoms and substance use were studied using linear regression separately for those with or without clozapine use. Age, gender, marital status, living situation and education were adjusted for in the final analyses. In the multivariable models, heavy alcohol use and binge drinking were less frequent among participants with clozapine use (n = 115) compared to those without (n = 161). Differences in some symptoms were observed in bivariate analyses when comparing the participants with and without heavy or binge drinking, or daily smoking. Heavy and binge drinking were associated with more severe grandiosity symptoms even after controlling for potential confounders. Daily smoking was associated with more severe hostility, elated mood, unusual thought content and uncooperativeness, but less severe emotional withdrawal. Symptom profiles and severity differed according to alcohol use or smoking. The possible explanations for the role of clozapine are discussed.
- Open Access
- 31 October 2025
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 42 (5-6) , 514-531
A Register-Based Follow-Up Study of Age-Specific Mortality and Causes of Death of Men, Women and Accompanying Children After Substance Use Treatment
Aim: This long-term follow-up study assessed substance related mortality by sex and compared it with the age-matched general population, with the aim of informing the development of treatment services. Methods: Data included 10,891 former patients who had sought treatment for substance use between 1990 and 2009, and a special group of 1,076 children who had accompanied their parent(s) to family treatment. Treatment data were linked to national register data concerning education, hospitalizations and death by 2019. Age-specific death rates, standardized mortality ratios and causes of death were compared with the Finnish general population. Results: By 2019, a larger proportion of the 7,334 treatment-seeking men (42.6%) than of the 3,557 women (27.4%) had died. The underlying cause of death was alcohol and/or drug related in one-third of the deaths and two-thirds when further causes were included. Age-specific comparisons with the general population revealed that the studied men and women had markedly higher death rates and the difference increased decade by decade, being highest among the youngest age-groups (standardized mortality ratios were 9.8 for men and 13.8 for women born in the 1980s). Out of the 1,076 children, 15 boys (2.8%) and four girls (0.7%) had died, mostly due to substance use or violence related causes. Conclusions: Mortality was significantly increased for several years after treatment highlighting the need for long-term follow-up, as well as after-care and easy re-entry to treatment. Special attention should be paid to the relatively higher increase in mortality risk among women.
- 31 October 2025
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 42 (5-6) , 514-531
Open AccessA Register-Based Follow-Up Study of Age-Specific Mortality and Causes of Death of Men, Women and Accompanying Children After Substance Use Treatment
Aim: This long-term follow-up study assessed substance related mortality by sex and compared it with the age-matched general population, with the aim of informing the development of treatment services. Methods: Data included 10,891 former patients who had sought treatment for substance use between 1990 and 2009, and a special group of 1,076 children who had accompanied their parent(s) to family treatment. Treatment data were linked to national register data concerning education, hospitalizations and death by 2019. Age-specific death rates, standardized mortality ratios and causes of death were compared with the Finnish general population. Results: By 2019, a larger proportion of the 7,334 treatment-seeking men (42.6%) than of the 3,557 women (27.4%) had died. The underlying cause of death was alcohol and/or drug related in one-third of the deaths and two-thirds when further causes were included. Age-specific comparisons with the general population revealed that the studied men and women had markedly higher death rates and the difference increased decade by decade, being highest among the youngest age-groups (standardized mortality ratios were 9.8 for men and 13.8 for women born in the 1980s). Out of the 1,076 children, 15 boys (2.8%) and four girls (0.7%) had died, mostly due to substance use or violence related causes. Conclusions: Mortality was significantly increased for several years after treatment highlighting the need for long-term follow-up, as well as after-care and easy re-entry to treatment. Special attention should be paid to the relatively higher increase in mortality risk among women.
- Open Access
- 30 September 2025
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 42 (5-6) , 424-446
Gambling Disorder and Increased Psychiatric Comorbidity: A Finnish Register-Based Study
Aim: This study investigates gender-specific standardized incidence ratios (SIRs) of comorbid psychiatric disorders among adults diagnosed with gambling disorder (GD) and also examines mortality rates and causes of death in this population. Methods: The study included all individuals aged 18 years or older in Finland diagnosed with GD between 2011 and 2022 ( n = 3,605), as defined by ICD-10 code F63.0 (International Classification of Diseases, 10th Revision). Data were drawn from nationwide social and healthcare registers, covering both primary and specialized care. The general population ( n = 4,374,192) served as the reference group. Results: Among individuals with GD, 88.5% were diagnosed with at least one additional psychiatric disorder. After age standardization, the incidence of psychiatric comorbidities was significantly higher in the GD group compared to the general population. Mood and anxiety disorders were the most common disorders in both groups. However, personality disorders (PD), schizophrenia spectrum disorders (SSD) and substance use disorders (SUD) were significantly more common among individuals with GD. Some gender-specific patterns emerged: GD was particularly associated with PD and SUD among women, as well as with PD and SSD among men. Of the GD cohort, 3.6% had died, with suicide accounting for 22% of deaths. Conclusions: Diagnosed GD is associated with elevated rates of psychiatric disorders, particularly PD, SSD and SUD. These findings highlight the importance of comprehensive mental health assessment in individuals with GD. Frontline social and healthcare professionals should be attentive to the high occurrence of psychiatric comorbidities in this population to ensure timely and appropriate care.
- 30 September 2025
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 42 (5-6) , 424-446
Open AccessGambling Disorder and Increased Psychiatric Comorbidity: A Finnish Register-Based Study
Aim: This study investigates gender-specific standardized incidence ratios (SIRs) of comorbid psychiatric disorders among adults diagnosed with gambling disorder (GD) and also examines mortality rates and causes of death in this population. Methods: The study included all individuals aged 18 years or older in Finland diagnosed with GD between 2011 and 2022 ( n = 3,605), as defined by ICD-10 code F63.0 (International Classification of Diseases, 10th Revision). Data were drawn from nationwide social and healthcare registers, covering both primary and specialized care. The general population ( n = 4,374,192) served as the reference group. Results: Among individuals with GD, 88.5% were diagnosed with at least one additional psychiatric disorder. After age standardization, the incidence of psychiatric comorbidities was significantly higher in the GD group compared to the general population. Mood and anxiety disorders were the most common disorders in both groups. However, personality disorders (PD), schizophrenia spectrum disorders (SSD) and substance use disorders (SUD) were significantly more common among individuals with GD. Some gender-specific patterns emerged: GD was particularly associated with PD and SUD among women, as well as with PD and SSD among men. Of the GD cohort, 3.6% had died, with suicide accounting for 22% of deaths. Conclusions: Diagnosed GD is associated with elevated rates of psychiatric disorders, particularly PD, SSD and SUD. These findings highlight the importance of comprehensive mental health assessment in individuals with GD. Frontline social and healthcare professionals should be attentive to the high occurrence of psychiatric comorbidities in this population to ensure timely and appropriate care.
- 5 March 2024
- Published by S. Karger AG in European Addiction Research
- Vol. 30 (3) , 140-141
Commentary on Bramness et al.: A Finnish Perspective on Addiction Training
Addictive disorders are one of the leading causes of disability and disease burden in Europe and beyond [1]. Unfortunately, this is not reflected in how resources for prevention and treatment of these disorders are allocated in Finland and we dare say in many other European countries.A need for improved training of health professionals, doctors very much included, has long since been identified. The study by Bramness et al. [2] examined the training of addiction specialist doctors and addiction psychologists in Europe, the latter of which Finland does not have. Even though treatment of addictions is very much a multi-professional team effort, and there are shortcomings in, e.g., nurses’ training in addictions, this commentary focuses on the situation and training needs of doctors in Finland.Addictive disorders are not adequately addressed in either basic medical training or any specialization training in Finland. Medical students may thus encounter patients with addictions mainly in, e.g., acute care settings where patients may be inebriated and perceived by staff as difficult. This leads to a distorted and incorrect view of people living with addictions and may result in the field of addiction medicine not perceived as very appealing. Without more comprehensive education in addictions in basic medical training, it is very often the case that doctors “fall into” the field of addiction medicine more or less by chance, as one colleague aptly put it. Stronger and more varied career paths in addiction medicine are warranted to engage young doctors.Addiction medicine is a special competence in Finland. It is not an individual specialty of medicine as in, e.g., Norway, nor is it integrated into psychiatric specialties, as is the case in many European countries. Finnish doctors have been able to engage in a training program leading to accreditation in addiction medicine since 1993 making addiction medicine one of the two oldest special competences we have. The training program including 2 to 3 years of clinical work is well established and run by the Finnish Society of Addiction Medicine (FiSAM). Final accreditation is provided by the Finnish Medical Association after review by and recommendation of the special competence board of FiSAM. Because of addiction medicine’s status as a special competence, and not a distinct medical specialty, there is no university support for running the training program.No resources outside of FiSAM are allocated to the special competence program. Colleagues involved with FiSAM work on a voluntary basis making the special competence program somewhat vulnerable and dependent on the input of a handful of active individuals. Employers of doctors in university-based medical specialty programs are reimbursed by universities for the trainees to participate in theoretical training, which provides incentives for employers to facilitate participation in training. The doctors enrolled in a special competence program have no funding from the universities or instances other than their employers. Further, although doctors in medical specialty training would benefit and want to include addiction medicine as part of their clinical medical specialty training, e.g., in general medicine, universities are often unwilling to allow this because addiction medicine is not a medical specialty.Not being a medical specialty not only has implications for teaching and training but for high-quality research in the field of addiction medicine. Finland does not have an academic research unit in addiction medicine. Thus, research funding is minimal, which may at least partly result from lack of university support. As reported by Bramness et al. [2], Finland has only three associate or full professor positions in addiction medicine. This limits the opportunities for research and pursuing a career in academic addiction medicine.Today, approximately 160 doctors have a special competence in addiction medicine. Not all are engaged in clinical work in the field of addictions. The most common medical specialties of doctors receiving accreditation are psychiatry and general medicine; however, in recent years a trend is being seen that more young doctors go directly into addiction medicine without carrying out specialist training. An encouraging sign is also that the number of applicants to the special competence program as well as those competing the accreditation has been rising, so we must be doing something right. There is still concern of how the special competence program in addiction medicine is able to meet the needs of treatment services where ever-growing substance use-related problems are becoming more and more diverse and complicated.Finland is facing a dire situation in health care with structural changes leading to decrease in funding throughout the health care system. Unfortunately, the past has demonstrated that in dire times, fiscal cuts to the health care system are often targeted at substance use and mental health services. What makes these prospectives even more concerning is the fact that Finland loses an allegorical jumbo jet of people each year to drugs, and in Finland these deaths occur among alarmingly young individuals compared to other European countries. Despite their young age, the deceased usually have history of long-term drug use and previous non-fatal overdoses but no addiction treatment. Every one of these premature deaths is potentially preventable with access to high quality treatment playing a key role. We strongly agree with Bramness et al. [2] that “harmonization of training, as is currently the case for other medical and psychology specializations, is warranted to ensure optimal treatment for this under-served patient group.”J.L. has received honoraria from Norsk forening for rus- og avhengighetsmedisin (NFRAM), Niuvanniemi hospital, Lundbeck/Otsuka, HY+, STEP Education, the Finnish Psychiatric Association, the Finnish...
- 5 March 2024
- Published by S. Karger AG in European Addiction Research
- Vol. 30 (3) , 140-141
Commentary on Bramness et al.: A Finnish Perspective on Addiction Training
Addictive disorders are one of the leading causes of disability and disease burden in Europe and beyond [1]. Unfortunately, this is not reflected in how resources for prevention and treatment of these disorders are allocated in Finland and we dare say in many other European countries.A need for improved training of health professionals, doctors very much included, has long since been identified. The study by Bramness et al. [2] examined the training of addiction specialist doctors and addiction psychologists in Europe, the latter of which Finland does not have. Even though treatment of addictions is very much a multi-professional team effort, and there are shortcomings in, e.g., nurses’ training in addictions, this commentary focuses on the situation and training needs of doctors in Finland.Addictive disorders are not adequately addressed in either basic medical training or any specialization training in Finland. Medical students may thus encounter patients with addictions mainly in, e.g., acute care settings where patients may be inebriated and perceived by staff as difficult. This leads to a distorted and incorrect view of people living with addictions and may result in the field of addiction medicine not perceived as very appealing. Without more comprehensive education in addictions in basic medical training, it is very often the case that doctors “fall into” the field of addiction medicine more or less by chance, as one colleague aptly put it. Stronger and more varied career paths in addiction medicine are warranted to engage young doctors.Addiction medicine is a special competence in Finland. It is not an individual specialty of medicine as in, e.g., Norway, nor is it integrated into psychiatric specialties, as is the case in many European countries. Finnish doctors have been able to engage in a training program leading to accreditation in addiction medicine since 1993 making addiction medicine one of the two oldest special competences we have. The training program including 2 to 3 years of clinical work is well established and run by the Finnish Society of Addiction Medicine (FiSAM). Final accreditation is provided by the Finnish Medical Association after review by and recommendation of the special competence board of FiSAM. Because of addiction medicine’s status as a special competence, and not a distinct medical specialty, there is no university support for running the training program.No resources outside of FiSAM are allocated to the special competence program. Colleagues involved with FiSAM work on a voluntary basis making the special competence program somewhat vulnerable and dependent on the input of a handful of active individuals. Employers of doctors in university-based medical specialty programs are reimbursed by universities for the trainees to participate in theoretical training, which provides incentives for employers to facilitate participation in training. The doctors enrolled in a special competence program have no funding from the universities or instances other than their employers. Further, although doctors in medical specialty training would benefit and want to include addiction medicine as part of their clinical medical specialty training, e.g., in general medicine, universities are often unwilling to allow this because addiction medicine is not a medical specialty.Not being a medical specialty not only has implications for teaching and training but for high-quality research in the field of addiction medicine. Finland does not have an academic research unit in addiction medicine. Thus, research funding is minimal, which may at least partly result from lack of university support. As reported by Bramness et al. [2], Finland has only three associate or full professor positions in addiction medicine. This limits the opportunities for research and pursuing a career in academic addiction medicine.Today, approximately 160 doctors have a special competence in addiction medicine. Not all are engaged in clinical work in the field of addictions. The most common medical specialties of doctors receiving accreditation are psychiatry and general medicine; however, in recent years a trend is being seen that more young doctors go directly into addiction medicine without carrying out specialist training. An encouraging sign is also that the number of applicants to the special competence program as well as those competing the accreditation has been rising, so we must be doing something right. There is still concern of how the special competence program in addiction medicine is able to meet the needs of treatment services where ever-growing substance use-related problems are becoming more and more diverse and complicated.Finland is facing a dire situation in health care with structural changes leading to decrease in funding throughout the health care system. Unfortunately, the past has demonstrated that in dire times, fiscal cuts to the health care system are often targeted at substance use and mental health services. What makes these prospectives even more concerning is the fact that Finland loses an allegorical jumbo jet of people each year to drugs, and in Finland these deaths occur among alarmingly young individuals compared to other European countries. Despite their young age, the deceased usually have history of long-term drug use and previous non-fatal overdoses but no addiction treatment. Every one of these premature deaths is potentially preventable with access to high quality treatment playing a key role. We strongly agree with Bramness et al. [2] that “harmonization of training, as is currently the case for other medical and psychology specializations, is warranted to ensure optimal treatment for this under-served patient group.”J.L. has received honoraria from Norsk forening for rus- og avhengighetsmedisin (NFRAM), Niuvanniemi hospital, Lundbeck/Otsuka, HY+, STEP Education, the Finnish Psychiatric Association, the Finnish...
- Open Access
- 22 January 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-10
Adolescent alcohol and cannabis use and early adulthood educational attainment in the 1986 Northern Finland birth cohort study
Background: Heavy alcohol and cannabis use during adolescence have been previously described as risk factors not only for morbidity in adulthood, but also social problems including adversities in educational attainment. Attempts to consider overlapping risk factors and confounders for these associations are needed. Methods: Using weighted multivariable models, we examined prospective associations between age at first drink (AFD), age at first intoxication (AFI), frequency of alcohol intoxication, as well as self-reported alcohol tolerance (i.e., number of drinks needed for the subjective experience of intoxication), and lifetime cannabis use at age 15/16 years with subsequent educational attainment obtained from comprehensive registers until age 33 in the Northern Finland Birth Cohort 1986 (6,564 individuals, 49.1% male). Confounding variables including sex, family structure (intact vs. non-intact), maternal and paternal education level, behavioural/emotional problems in school at age 7/8 years, having a history of illicit substance use in adolescence, having any psychiatric diagnosis before age 16, and parental psychiatric diagnoses, were adjusted for. Results: In this large birth cohort study with a 17-year follow-up, younger age at first intoxication, higher frequency of alcohol intoxication, and high self-reported alcohol tolerance at age 15/16 years were associated with poorer educational outcomes by the age of 33 years. These associations were evident regardless of potential confounders, including parental education and childhood behavioural/emotional problems. The association between adolescent cannabis use and educational attainment in adulthood was no longer statistically significant after adjusting for confounders including frequency of alcohol intoxication at age 15/16. Conclusions: Assessments of age of first alcohol intoxication, high self-reported alcohol tolerance and frequency of intoxication during adolescence should be included when implementing screening strategies aimed at identifying adolescents at risk for subsequent social problems.
- 22 January 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-10
Open AccessAdolescent alcohol and cannabis use and early adulthood educational attainment in the 1986 Northern Finland birth cohort study
Background: Heavy alcohol and cannabis use during adolescence have been previously described as risk factors not only for morbidity in adulthood, but also social problems including adversities in educational attainment. Attempts to consider overlapping risk factors and confounders for these associations are needed. Methods: Using weighted multivariable models, we examined prospective associations between age at first drink (AFD), age at first intoxication (AFI), frequency of alcohol intoxication, as well as self-reported alcohol tolerance (i.e., number of drinks needed for the subjective experience of intoxication), and lifetime cannabis use at age 15/16 years with subsequent educational attainment obtained from comprehensive registers until age 33 in the Northern Finland Birth Cohort 1986 (6,564 individuals, 49.1% male). Confounding variables including sex, family structure (intact vs. non-intact), maternal and paternal education level, behavioural/emotional problems in school at age 7/8 years, having a history of illicit substance use in adolescence, having any psychiatric diagnosis before age 16, and parental psychiatric diagnoses, were adjusted for. Results: In this large birth cohort study with a 17-year follow-up, younger age at first intoxication, higher frequency of alcohol intoxication, and high self-reported alcohol tolerance at age 15/16 years were associated with poorer educational outcomes by the age of 33 years. These associations were evident regardless of potential confounders, including parental education and childhood behavioural/emotional problems. The association between adolescent cannabis use and educational attainment in adulthood was no longer statistically significant after adjusting for confounders including frequency of alcohol intoxication at age 15/16. Conclusions: Assessments of age of first alcohol intoxication, high self-reported alcohol tolerance and frequency of intoxication during adolescence should be included when implementing screening strategies aimed at identifying adolescents at risk for subsequent social problems.
- Open Access
- 23 August 2023
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 33 (6) , 1115-1121
Adolescent alcohol and cannabis use as risk factors for head trauma in the Northern Finland Birth Cohort study 1986
The aim of this study was to assess the associations between cannabis use and frequency of alcohol intoxication in adolescence with the risk of traumatic brain injury and craniofacial fractures in early adulthood. Hypothesis was that using alcohol and cannabis in adolescence could increase the risk for head traumas. Data from the Northern Finland Birth Cohort 1986 (n = 9432 individuals) were used to investigate the prospective association between the self-reported frequency of alcohol intoxication (n = 6472) and cannabis use (n = 6586) in mid-adolescence and register-based, head trauma diagnoses by ages 32–33 years. To test the robustness of these associations, the statistical models were adjusted for a range of other confounders such as illicit drug use, previous head trauma and self-reported mental health problems. In multivariate analyses, cannabis use was statistically significantly associated with a greater risk of traumatic brain injury among females [hazard ratio (HR) 1.9, 95% confidence interval (CI) 1.1–3.2, P = 0.024). Frequent alcohol intoxication was a statistically significant independent risk factor for both traumatic brain injury (HR 2.6, 95% CI 1.7–3.9, P < 0.001) and craniofacial fractures (HR 2.7, 95% CI 1.6–4.8, P < 0.001) among males. Cannabis use in adolescence appears to associate independently with elevated risk for traumatic brain injury among females, and frequent alcohol intoxication in adolescence seems to associate with elevated risk of both traumatic brain injury and craniofacial fractures among males.
- 23 August 2023
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 33 (6) , 1115-1121
Open AccessAdolescent alcohol and cannabis use as risk factors for head trauma in the Northern Finland Birth Cohort study 1986
The aim of this study was to assess the associations between cannabis use and frequency of alcohol intoxication in adolescence with the risk of traumatic brain injury and craniofacial fractures in early adulthood. Hypothesis was that using alcohol and cannabis in adolescence could increase the risk for head traumas. Data from the Northern Finland Birth Cohort 1986 (n = 9432 individuals) were used to investigate the prospective association between the self-reported frequency of alcohol intoxication (n = 6472) and cannabis use (n = 6586) in mid-adolescence and register-based, head trauma diagnoses by ages 32–33 years. To test the robustness of these associations, the statistical models were adjusted for a range of other confounders such as illicit drug use, previous head trauma and self-reported mental health problems. In multivariate analyses, cannabis use was statistically significantly associated with a greater risk of traumatic brain injury among females [hazard ratio (HR) 1.9, 95% confidence interval (CI) 1.1–3.2, P = 0.024). Frequent alcohol intoxication was a statistically significant independent risk factor for both traumatic brain injury (HR 2.6, 95% CI 1.7–3.9, P < 0.001) and craniofacial fractures (HR 2.7, 95% CI 1.6–4.8, P < 0.001) among males. Cannabis use in adolescence appears to associate independently with elevated risk for traumatic brain injury among females, and frequent alcohol intoxication in adolescence seems to associate with elevated risk of both traumatic brain injury and craniofacial fractures among males.